查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413855

天冬醯胺市場：按類型、應用分類 - 2024-2030 年全球預測

Asparagine Market by Type (Asparagine Anhydrous, Asparagine Monohydrate), Application (Food & Beverage, Pharmaceutical) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年天門冬胺酸市場規模為118.1億美元，2024年達124億美元，預計2030年將達到169.6億美元，複合年成長率為5.29%。

天冬醯胺的全球市場

主要市場統計
基準年[2023] 118.1億美元
預測年份 [2024] 124億美元
預測年份 [2030] 169.6億美元
複合年成長率（%） 5.29%
天冬醯胺市場-IMG1

天冬醯胺是一種胺基酸，在蛋白質生物合成中發揮重要作用。它是大腦發育和功能的重要組成部分，也是神經傳導物質的前體。天冬醯胺市場涵蓋生物技術、食品和飲料、藥品和動物飼料等各個行業，展示了其廣泛的頻譜。分析市場需要深入了解其應用、最終用途、市場規模、成長機會因素、限制、創新潛力等。人們對營養補充健康意識的增強食品製藥業研發投資的增加正在推動市場成長。食品和飲料產業不斷的技術創新也在推動市場發展。原料價格的波動、有關天冬醯胺使用的嚴格法規和標準限制了市場的成長。含天冬醯胺的新型藥物製劑的市場開拓、精準醫療和標靶治療的興起預計將為市場提供機會。

區域洞察

美洲天冬醯胺市場的特點是生物技術領域的進步，尤其是在北美。天冬醯胺在美國的生產和消費主要用於製藥和食品工業。南美市場正在興起，巴西食品添加劑應用和研究對天冬醯胺的需求不斷增加。北美有關食品添加劑和臨床營養的嚴格法規正在推動對高純度天冬醯胺的需求。在主導中國、日本和印度為首的亞太地區，由於製藥、食品以及食品和食品和飲料行業的成長，天冬醯胺市場正在迅速擴大。中國大規模的生產能力使其成為國內外天冬醯胺的重要供應國。該地區正在經歷營養和保健補充食品行業的成長，推動了對天冬醯胺等氨基酸的需求。不斷變化的監管環境和不斷增強的消費者健康意識正在進一步塑造市場動態。在 EMEA（歐洲、中東和非洲），歐洲引領天冬胺酸的成熟市場，特別是在製藥和營養補充食品。人口的穩定老化導致該地區對含天冬醯胺的營養補充和腸外營養的巨大需求。中東和非洲市場有待開拓，但由於健康意識的提高和飲食習慣的改變，具有成長潛力。

FPNV定位矩陣

FPNV定位矩陣對於評估天門冬胺酸市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對天冬醯胺市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-天冬胺酸市場的市場規模和預測是多少？

2-天冬胺酸市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-天冬醯胺市場的技術趨勢和法律規範是什麼？

4-天冬胺酸市場主要供應商的市場佔有率是多少？

5-進入天冬醯胺市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 健康意識增強，營養補充食品需求增加
      • 加大醫藥產業研發投入
      • 食品和飲料產業持續創新
    • 抑制因素
      • 原物料價格波動
    • 機會
      • 開發含有天冬醯胺的新藥物製劑。
      • 精準醫學和標靶治療的興起
    • 任務
      • 嚴格的天冬醯胺使用法規和標準
  • 市場區隔分析
    • 類型：乾混營養配方中對無水天冬醯胺的需求不斷增加
    • 應用：增加天冬醯胺的使用，以提高產品的營養價值和風味特徵
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章天冬醯胺市場：依類型

  • 無水天冬醯胺
  • 天門冬胺酸一水化合物

第7章天冬醯胺市場：依應用分類

  • 食品和飲料
  • 藥品

第8章 美洲天冬胺市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區天冬胺市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲天冬胺市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 獎項/獎勵/擴展

第12章競爭產品組合

  • 主要公司簡介
    • BioVendor Group
    • Creative Enzymes
    • Duchefa Biochemie BV
    • Jazz Pharmaceuticals, Inc.
    • LGC Limited
    • medac GmbH
    • Merck KGaA
    • MP Biomedicals, LLC
    • Porton Biopharma Limited
    • Taj Pharmaceuticals Ltd.
    • Tokyo Chemical Industry（India）Pvt. Ltd.
    • VWR International, LLC
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C1290E70D508

[183 Pages Report] The Asparagine Market size was estimated at USD 11.81 billion in 2023 and expected to reach USD 12.40 billion in 2024, at a CAGR 5.29% to reach USD 16.96 billion by 2030.

Global Asparagine Market

KEY MARKET STATISTICS
Base Year [2023] USD 11.81 billion
Estimated Year [2024] USD 12.40 billion
Forecast Year [2030] USD 16.96 billion
CAGR (%) 5.29%
Asparagine Market - IMG1

Asparagine, an amino acid, plays a fundamental role in the biosynthesis of proteins. It is an essential component required for the development and functioning of the brain and is a precursor to neurotransmitters. The asparagine market spans various industries, including biotechnology, food and beverage, pharmaceuticals, and animal feed, showcasing its broad spectrum of utilizations. Analyzing the market requires insights into its applications, end-uses, market scope, growth opportunity factors, limitations, and potential areas of innovation. Rising health consciousness for dietary supplements and increased investment in R&D in the pharmaceutical industry are driving the market growth. Ongoing innovations in the food and beverage industry are also propelling the market. Fluctuations in the prices of raw materials and stringent regulations and standards regarding the use of asparagine are restricting market growth. The development of novel pharmaceutical formulations containing asparagine and the rise in precision medicine and targeted therapies are expected to create opportunities in the market.

Regional Insights

The Asparagine market in the Americas is characterized by advanced biotechnology sectors, particularly in North America. The United States produces and consumes Asparagine, predominantly for the pharmaceuticals and food industries. South America's market is emerging, with Brazil showing increasing demand for Asparagine in food additive applications and research. Stringent regulations on North American food additives and clinical nutrition bolster the demand for high-purity Asparagine. The Asia-Pacific, led by China, Japan, and India, has a rapidly expanding asparagine market due to its growing pharmaceutical, food, and beverage industries. China's large-scale manufacturing capabilities make it a significant supplier of Asparagine domestically and globally. The region is witnessing growth in nutrition and health supplement sectors, driving the need for amino acids such as Asparagine. The evolving regulatory landscape and increasing consumer health consciousness further shape the market dynamics. In EMEA, Europe leads with a mature market for Asparagine, particularly within the pharmaceutical and nutraceutical industries. The steadily aging population contributes to the region's significant demand for dietary supplements and parenteral nutrition, which includes Asparagine. The market needs to be developed in the Middle East and Africa but presents potential for growth with rising health awareness and changing dietary habits.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asparagine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asparagine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asparagine Market, highlighting leading vendors and their innovative profiles. These include BioVendor Group, Creative Enzymes, Duchefa Biochemie B.V., Jazz Pharmaceuticals, Inc., LGC Limited, medac GmbH, Merck KGaA, MP Biomedicals, LLC, Porton Biopharma Limited, Taj Pharmaceuticals Ltd., Tokyo Chemical Industry (India) Pvt. Ltd., and VWR International, LLC.

Market Segmentation & Coverage

This research report categorizes the Asparagine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Asparagine Anhydrous
    • Asparagine Monohydrate
  • Application
    • Food & Beverage
    • Pharmaceutical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Asparagine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asparagine Market?

3. What are the technology trends and regulatory frameworks in the Asparagine Market?

4. What is the market share of the leading vendors in the Asparagine Market?

5. Which modes and strategic moves are suitable for entering the Asparagine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Asparagine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising health consciousness and demand for dietary supplements
      • 5.1.1.2. Increased investment for R&D in pharmaceutical industry
      • 5.1.1.3. Ongoing innovations in the food and beverage industry
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuations in prices of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of novel pharmaceutical formulations containing asparagine.
      • 5.1.3.2. Rise in precision medicine and targeted therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards regarding the use of asparagine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type:Growing demand for Anhydrous asparagine in dry-blending nutritional formulations
    • 5.2.2. Application: Rising usage of Asparagine for enhancing nutritional value and flavor profiles of products
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Asparagine Market, by Type

  • 6.1. Introduction
  • 6.2. Asparagine Anhydrous
  • 6.3. Asparagine Monohydrate

7. Asparagine Market, by Application

  • 7.1. Introduction
  • 7.2. Food & Beverage
  • 7.3. Pharmaceutical

8. Americas Asparagine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Asparagine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Asparagine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Agreement, Collaboration, & Partnership
      • 11.3.1.1. Kaimisi New Material and Bicells to build 2,000 t per year L-asparagine project and 100 t per year GABA project
    • 11.3.2. Award, Recognition, & Expansion
      • 11.3.2.1. Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. BioVendor Group
    • 12.1.2. Creative Enzymes
    • 12.1.3. Duchefa Biochemie B.V.
    • 12.1.4. Jazz Pharmaceuticals, Inc.
    • 12.1.5. LGC Limited
    • 12.1.6. medac GmbH
    • 12.1.7. Merck KGaA
    • 12.1.8. MP Biomedicals, LLC
    • 12.1.9. Porton Biopharma Limited
    • 12.1.10. Taj Pharmaceuticals Ltd.
    • 12.1.11. Tokyo Chemical Industry (India) Pvt. Ltd.
    • 12.1.12. VWR International, LLC
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ASPARAGINE MARKET RESEARCH PROCESS
  • FIGURE 2. ASPARAGINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ASPARAGINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ASPARAGINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ASPARAGINE MARKET DYNAMICS
  • FIGURE 7. ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ASPARAGINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ASPARAGINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ASPARAGINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ASPARAGINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ASPARAGINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ASPARAGINE MARKET SIZE, BY ASPARAGINE ANHYDROUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ASPARAGINE MARKET SIZE, BY ASPARAGINE MONOHYDRATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. ASPARAGINE MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ASPARAGINE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES ASPARAGINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA ASPARAGINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM ASPARAGINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ASPARAGINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. ASPARAGINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. ASPARAGINE MARKET LICENSE & PRICING